Dr. Trevor Martin is the CEO and co-founder of Mammoth Biosciences, which addresses challenges across healthcare, agriculture, environmental monitoring, biodefense, and more through discovery of novel CRISPR systems to power the next generation of CRISPR-based synthetic biology products. Ursheet Parikh is a partner at the venture capital firm Mayfield, where he co-leads the Human and Planetary Health investment practice, which includes an investment in Mammoth. In this conversation with Stanford adjunct lecturer Ravi Belani, Martin and Parikh share their advice for building a platform biotech company with staying power.
Related
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.
